Women’s Health Collective Canada (WHCC) is proud to announce the launch of Vital Talks, a new national online seminar series bringing together leading researchers, clinicians, and voices with lived ...

Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up. Enrollment for registrational Phase 3 portion of KYSA-6 trial in MG ...

AdCare Rhode Island has been a vital part of this community for many years, and I am honored to have the opportunity to lead our team into the future,” Paliotti said. “This is such an exciting time, ...

Of the laboratory’s accreditation, Dr. Jordan Olson, Chief Medical Officer and Chair of Pathology at HNL Lab Medicine, said: “Our community depends on accurate, timely, and reliable laboratory testing ...

Partnership strengthens Nugevia™ launch bringing clinical and scientific integrity to the fast-growing longevity space ...

With more than 40,000 patients treated so far, Smile Hair Clinic continues to be a pioneer in the field of advanced hair transplantation with natural-looking results and cutting-edge technology.

WASHINGTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- On Sept. 10, more than 50 citizen lobbyists representing a consortium of 15 national nonprofits and organizations gathered on Capitol Hill for the first ...

Villepinte, 15 September 2025, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward revision to its financial ...

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced a poster ...

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces that the final results ...

Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today executed a licensing agreement with Kwangdong Pharmaceutical, ...

(GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced that the company will present information on two of its investigational small ...